The standard price for one cycle of palbociclib is £2,950 for a pack of 21 capsules. The list price for one cycle of ribociclib is also £2,950 but this is for 63 tablets. The Institute of Cancer Research (ICR), London, described the drugs as among the “most important breakthroughs” for women with advanced cancer in the last two decades. Around 8,000 people in England with previously untreatable breast cancer will now have access to palbociclib and ribociclib which have been shown to slow the progression of advanced cancer by at least 10 months, and can delay the need for chemotherapy. Thousands to benefit as 'breakthrough' breast cancer drugs approved for NHS use Read moreThe latest draft guidance from Nice said that women with oestrogen receptor positive breast cancer that is diagnosed after it has begun to spread will be eligible for palbociclib - also known as Ibrance.

Source: The Guardian November 16, 2017 16:41 UTC